3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Stomatitis
1
Mucositis
1
Interventions
Cyclophosphamide
518
Bevacizumab
488
Carboplatin
424
pembrolizumab
389
Paclitaxel
385
Gemcitabine
372
Cisplatin
366
Docetaxel
323
Rituximab
317
Radiotherapy
296
Nivolumab
247
Doxorubicin
244
Dexamethasone
240
Fluorouracil
225
Capecitabine
214
Oxaliplatin
211
Erlotinib Hydrochloride
206
fludarabine phosphate
201
Etoposide
188
Cetuximab
186
Lenalidomide
177
Pemetrexed
176
Bortezomib
174
Trastuzumab
173
Filgrastim
171
Prednisone
167
fludarabine
166
Leucovorin
166
Cytarabine
166
Irinotecan
161
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Has results
×
Poloxamer
×
Clear all
NCT01898091
2017-03-06
OM
Medical University of South Carolina
Phase 2
Completed
50 enrolled
9 charts